Skip to main content

ORMP

Oramed Pharmaceuticals Inc.

Company with tickers: ORMP

CIK
1176309
CUSIP
68403P203
Shares Outstanding
40,926,081
13F Activity (30d)
27 filings 24 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 45
Total Value: $41,039,806
Total Shares: 12,070,536

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 45 13F filers
Top Holder
26.2%
Dec 2023 → Mar 2026 · range 24.3% – 42.3%
of institutional value
Top 5
84.1%
Dec 2023 → Mar 2026 · range 66.8% – 88.0%
of institutional value
Top 10
95.5%
Dec 2023 → Mar 2026 · range 84.3% – 96.1%
of institutional value
HHI
1,586
Dec 2023 → Mar 2026 · range 1,266 – 2,532
Moderately concentrated

Quarterly Activity

vs Jan 14, 2026
New
44
Increased
1
Decreased
0
Sold Out
0
Unchanged
0
Holder count: +44
Institutional value: +450.6%
Shares held: +489.5%

Top Buyers

vs Jan 14, 2026
Institution Added Now Holds Open

Top Sellers

vs Jan 14, 2026
No qualifying movers this quarter.

Top New Positions

vs Jan 14, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jan 14, 2026
No fully closed positions this quarter.
Showing 45 of 45
Export CSV
Holder Value (USD) % of 13F Shares Open